Lei Wang et al.
FULL PAPERS
CDCl3): d=144.5, 123.4, 111.9, 108.9, 105.2, 82.8, 81.7, 81.1,
72.4, 67.4, 64.1, 57.9, 55.5, 46.7, 29.1, 26.8, 26.2, 25.5; anal.
calcd. for C20H32N4O6: C 56.59, H 7.60, N 13.20; found: C
56.81, H 7.38, N 13.52.
4H, 2ꢂCH2), 1.30–1.17 (m, 1H, CH); 13C NMR (100 MHz,
CDCl3): d=210.8, 148.4, 140.2, 134.6, 129.9, 122.8, 78.2, 52.0,
43.4, 42.5, 33.3, 28.2, 25.0; HPLC (Chiralpak AD-H, 2-prop-
anol/hexane=10/90, flow rate 1.0 mLminÀ1, l=254 nm):
(S)-2-[(R)-2-Nitro-1-phenylethyl]cyclohexanone:[38]
tminor =11.92 min, tmajor =18.67 min; dr (syn/anti)=99:1; ee=
1H NMR (400 MHz, CDCl3): d=7.34–7.23 (m, 3H, ArH),
7.16 (d, J=7.3 Hz, 2H, ArH), 4.92 (dd, J=4.5, 12.3 Hz, 1H,
CH), 4.66 (dd, J=9.9, 12.0 Hz, 1H, CH), 3.75 (dt, J=4.5,
9.9 Hz, 1H, CH), 2.70–2.67 (m, 1H, CH), 2.49–2.45 (m, 1H,
CH), 2.43–2.36 (m, 1H, CH), 2.14–2.05 (m, 1H, CH), 1.78–
1.60 (m, 4H, 2ꢂCH2), 1.28–1.21 (m, 1H, CH); 13C NMR
(100 MHz, CDCl3): d=211.6, 137.5, 128.9, 128.3, 127.6, 78.8,
52.4, 43.9, 42.9, 33.1, 28.4, 25.2; HPLC (Chiralpak AD-H, 2-
propanol/hexane=10/90, flow rate 1.0 mLminÀ1, l=
254 nm): tminor =10.34 min, tmajor =13.23 min; dr (syn/anti)=
99:1; ee=99%; [a]2D5: À23.2 (c 1.2, CHCl3).
99%; [a]25: À28.2 (c 1.2, CHCl3).
(S)-2-[D(R)-1-(3-Bromophenyl)-2-nitroethyl]cyclohexa-
none:[39] 1H NMR (400 MHz, CDCl3): d=7.41 (d, J=7.7 Hz,
1H, ArH), 7.38 (s, 1H, ArH), 7.20 (t, J=7.9 Hz, 1H, ArH),
7.12 (d, J=7.2 Hz, 1H, ArH), 4.93 (dd, J=4.5, 12.7 Hz, 1H,
CH), 4.62 (dd, J=10.0, 12.7 Hz, 1H, CH), 3.77–3.71 (m, 1H,
CH), 2.64–2.58 (m, 1H, CH), 2.48–2.37 (m, 2H, CH2), 2.07–
2.04 (m, 1H, CH), 1.78–1.55 (m, 4H, 2ꢂCH2), 1.31–1.21 (m,
1H, CH); 13C NMR (100 MHz, CDCl3): d=211.1, 140.2,
131.2, 130.8, 130.5, 126.8, 122.7, 78.2, 52.2, 43.7, 42.7, 33.1,
28.4, 25.1; HPLC (Chiralpak AD-H, 2-propanol/hexane=
10/90, flow rate 1.0 mLminÀ1, l=254 nm): tminor =9.41 min,
(S)-2-[(R)-1-(4-Methylphenyl)-2-nitroethyl]cyclohexa-
none:[38] 1H NMR (400 MHz, CDCl3): d=7.12 (d, J=8.2 Hz,
2H, ArH), 7.03 (d, J=8.0 Hz, 2H, ArH), 4.90 (dd, J=4.7,
12.0 Hz, 1H, CH), 4.62 (dd, J=9.3, 11.9 Hz, 1H, CH), 3.73
(dt, J=4.6, 10.0 Hz, 1H, CH), 2.64–2.58 (m, 1H, CH), 2.46–
2.43 (m, 1H, CH), 2.39–2.35 (m, 1H, CH) 2.32 (s, 3H, CH3),
1.78–1.76 (m, 1H, CH), 1.76–1.55 (m, 4H, 2ꢂCH2), 1.24–
1.21(m, 1H, CH); 13C NMR (100 MHz, CDCl3): d=212.1,
137.5, 134.6, 129.6, 128.0, 79.2, 52.6, 43.7, 42.5, 33.4, 28.5,
25.1, 21.0; HPLC (Chiralpak AD-H, 2-propanol/hexane=
10/90, flow rate 1.0 mLminÀ1, l=254 nm): tminor =8.99 min,
t
major =10.35 min; dr (syn/anti)=98:2; ee=93%; [a]2D5: À31.5
(c 1.2, CHCl3).
(S)-2-[(R)-1-(2-Bromophenyl)-2-nitroethyl]cyclohexa-
none:[28] 1H NMR (400 MHz, CDCl3): d=7.59 (d, J=8.2 Hz,
1H, ArH), 7.31–7.20 (m, 2H, ArH), 7.14–7.12 (m, 1H,
ArH), 4.88 (d, J=8.0 Hz, 2H, CH2), 4.31 (dd, J=6.3, 6.8 Hz,
1H, CH), 2.91–2.85 (m, 1H, CH), 2.48–2.34 (m, 2H, CH2),
2.12–2.06 (m, 1H, CH), 1.82–1.57 (m, 4H, 2ꢂCH2), 1.40–
1.22 (m, 1H, CH); 13C NMR (100 MHz, CDCl3): d=211.4,
137.3, 133.4, 129.2, 127.8, 77.2, 52.4, 43.1, 42.5, 41.8, 32.7,
28.4, 25.2; HPLC (Chiralpak AD-H, 2-propanol/hexane=
10/90, flow rate 1.0 mLminÀ1, l=254 nm): tminor =10.34 min,
t
major =12.34 min; dr (syn/anti)> 99:1; ee>99%; [a]2D5: À25.8
(c 1.2, CHCl3).
(S)-2-[(R)-1-(4-Methoxyphenyl)-2-nitroethyl]cyclohexa-
none:[14] 1H NMR (400 MHz, CDCl3): d=7.06 (d, J=8.3 Hz,
2H, ArH), 6.82 (d, J=8.9 Hz, 2H, ArH), 4.94 (dd, J=4.5,
12.2 Hz, 1H, CH), 4.56 (dd, J=10.2, 12.3 Hz, 1H, CH), 3.77
(s, 3H, OCH3), 3.72 (dt, J=4.8, 10.4 Hz, 1H, CH), 2.65–2.63
(m, 1H, CH), 2.54–2.43 (m, 1H, CH), 2.44–2.36 (m, 1H,
CH), 2.13–2.06 (m, 1H, CH), 1.82–1.57 (m, 4H, 2ꢂCH2),
1.25–1.20 (m, 1H, CH); 13C NMR (100 MHz, CDCl3): d=
212.2, 137.4, 134.6, 129.6, 128.2, 79.0, 52.6, 43.5, 42.6, 33.4,
28.5, 25.1, 21.0; HPLC (Chiralpak AD-H, 2-propanol/
t
major =18.06 min; dr (syn/anti)=99:1; ee=98%; [a]2D5: À51.8
(c 1.2, CHCl3).
(S)-2-[(R)-1-(4-Fluorophenyl)-2-nitroethyl]cyclohexa-
none:[38] 1H NMR (400 MHz, CDCl3): d=7.14 (d, J=8.2 Hz,
2H, ArH), 7.02 (d, J=8.5 Hz, 2H, ArH), 4.93 (dd, J=4.5,
12.6 Hz, 1H, CH), 4.57 (dd, J=10.0, 12.4 Hz, 1H, CH),
3.81–3.73 (m, 1H, CH), 2.64–2.60 (m, 1H, CH), 2.48–2.38
(m, 2H, CH2), 2.09–2.07 (m, 1H, CH), 1.79–1.58 (m, 4H, 2ꢂ
CH2), 1.24–1.21 (m, 1H, CH); 13C NMR (100 MHz, CDCl3):
d=211.5, 133.4, 129.6, 129.4, 124.7, 124.6, 116.5, 115.3, 78.9,
52.3, 43.1, 42.7, 33.0, 28.4, 25.2; HPLC (Chiralpak AD-H, 2-
propanol/hexane=10/90, flow rate 1.0 mLminÀ1, l=
254 nm): tminor =16.45 min, tmajor =25.57 min; dr (syn/anti)=
99:1; ee=96%; [a]2D5: À32.6 (c 1.2, CHCl3).
hexane=10/90, flow rate 1.0 mLminÀ1, l=254 nm): tminor
=
11.99 min, tmajor =15.75 min; dr (syn/anti)=99:1; ee=99%;
[a]25: À21.8 (c 1.2, CHCl3).
(DS)-2-[(R)-1-(4-Trifluoromethylphenyl)-2-nitroethyl]cyclo-
hexanone:[14] 1H NMR (400 MHz, CDCl3): d=7.61 (d, J=
8.0 Hz, 2H, ArH), 7.30 (d, J=8.0 Hz, 2H, ArH), 4.97 (dd,
J=12.8, 4.5 Hz, 1H, CH), 4.65 (dd, J=12.8, 10.0 Hz, 1H,
CH), 3.87 (dt, 1H, J=10.0, 4.5 Hz, ArCH), 2.73–2.65 (m,
1H, CH), 2.50–2.49 (m, 1H, CH), 2.41–2.33 (m, 1H, CH),
2.15–2.05 (m, 1H, CH), 1.82–1.75 (m, 1H, CH), 1.75–1.66
(m, 2H, CH2), 1.64–1.56 (m, 1H, CH), 1.29–1.20 (m, 1H,
CH); 13C NMR (100 MHz, CDCl3): d=212.3, 149.2, 148.7,
130.2, 120.5, 111.8, 79.4, 56.2, 52.6, 43.8, 42.6, 33.4, 28.5, 27.6,
25.1; HPLC (Chiralpak AD-H, 2-propanol/hexane=5/95,
(S)-2-[(R)-1-(4-Chlorophenyl)-2-nitroethyl]cyclohexa-
none:[38] 1H NMR (400 MHz, CDCl3): d=7.31 (d, J=8.3 Hz,
2H, ArH), 7.16 (d, J=8.4 Hz, 2H, ArH), 4.92 (dd, J=4.6,
12.5 Hz, 1H, CH), 4.64 (dd, J=10.0, 12.6 Hz, 1H, CH),
3.78–3.72 (m, 1H, CH), 2.73–2.64 (m, 1H, CH), 2.46–2.36
(m, 2H, CH2), 2.12–2.04 (m, 1H, CH), 1.77–1.56 (m, 4H, 2ꢂ
CH2), 1.26–1.23 (m, 1H, CH); 13C NMR (100 MHz, CDCl3):
d=211.4, 136.3, 133.4, 129.7, 129.1, 122.8, 78.4, 52.4, 43.2,
42.6, 33.4, 29.5, 28.4, 25.2; HPLC (Chiralpak AD-H, 2-prop-
anol/hexane=10/90, flow rate 1.0 mLminÀ1, l=254 nm):
flow rate 1.0 mLminÀ1, l=254 nm): tminor =16.78 min, tmajor
=
tminor =27.41 min, tmajor =41.83 min; dr (syn/anti)=98:2; ee=
36.24 min; dr (syn/anti)>99:1; ee>99%; [a]2D5: À20.6 (c 1.2,
99%; [a]25: À38.1 (c 1.2, CHCl3).
CHCl3).
(S)-2-[D(R)-1-(2-Chlorophenyl)-2-nitroethyl]cyclohexa-
none:[38] 1H NMR (400 MHz, CDCl3): d 7.36 (d, J=8.0 Hz,
1H, ArH), 7.27–7.21 (m, 3H, ArH), 4.94–4.88 (m, 2H,
CH2), 4.31–4.25 (m, 1H, CH), 2.96–2.90 (m, 1H, CH), 2.46–
2.38 (m, 2H, CH2), 2.12–2.07 (m, 1H, CH), 1.82–1.57 (m,
4H, 2ꢂCH2), 1.27–1.23 (m, 1H, CH); 13C NMR (100 MHz,
CDCl3): d=211.4, 135.5, 134.4, 130.3, 129.3, 128.7, 127.2,
(S)-2-[(R)-1-(4-Bromophenyl)-2-nitroethyl]cyclohexa-
none:[38] 1H NMR (400 MHz, CDCl3): d=7.46 (d, J=8.7 Hz,
2H, ArH), 7.05 (d, J=8.4 Hz, 2H, ArH), 4.93 (dd, J=4.5,
12.6 Hz, 1H, CH), 4.62 (dd, J=9.9, 12.6 Hz, 1H, CH), 3.76
(dt, J=4.5, 9.9 Hz, 1H, CH), 2.68–2.57 (m, 1H, CH), 2.53–
2.30 (m, 2H, CH2), 2.14–2.05 (m, 1H, CH), 1.82–1.53 (m,
2576
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2010, 352, 2571 – 2578